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Abstract
Equine Strangles, an upper respiratory disease caused by Streptococcus equi
subspecies equi (S. equi) causes significant losses in the horse industry. Surveillance for
S. equi could be facilitated by quantifying S. equi in environmental samples. The
objective of this project was to evaluate ELISA in quantifying S. equi using two
monoclonal antibodies (MAB’s) to the SeM protein (MAB-212 for capture, and
biotinylated MAB-211 for detection), with Streptococcal phage lysin releasing SeM from
the cell surface. Initial results confirmed a fresh culture of S. equi and two S. equi lysates
stored at -20 C for 2 years as positive, while confirming as negative a stored lysate of
Streptococcus equi subspecies zooepidemicus. A standard curve was created using 12
serial dilutions at 1:10 of S. equi and colony counts determined for each of the 12
dilutions. Eight serial dilutions at 1:2 of these 12 dilutions then yielded one dilution for
each well in a 96 well plate. Regression of absorbance against colony counts showed that
ELISA was successful in quantifying between 78,125 CFU/mL and 15,000 CFU/mL of S.
equi, with an R2 of 0.93. Water was then seeded with S. equi, and 3 swab samples taken,
dispersed in PBS, and the 3 suspensions serially diluted 1:10 to provide 4 dilutions (12
total). Colony counts were determined by plating 100 µL of each dilution. All dilutions
tested positive for S. equi, but there was no correlation between absorbance and colony
counts (R2= 0.0028), possibly due to plate contamination.
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Figure 1. Initial validation of ELISA assay. Row A1-A12: serially diluted S. equi. Row
B1-B12: 100 fold dilution of row A. Row C1-C12: 10,000 dilution of row A.
Rows D1-12 and E1-E12: Buffer only. Row F1-F12: 2012 Lysate # 1 of S. equi.
Row G1-G12: 2012 Lysate # 2 of S. equi. Row H1-H12: 2012 Lysate of S.
zooepidemicus.
Figure 2. Same as Figure 1, following addition of stop solution (0.6 N HCl).
Figure 3. Graphical representation of absorbance readings (450 nm) following ELISA of
96 different concentrations of S. equi.
Figure 4. Regression of absorbance values derived from ELISA of S. equi at 	
  
concentrations in the linear region of the standard curve shown in Figure 3.	
  
Figure 5. ELISA plate from standard curve calculation after the addition of
tetramethylbenzidine, but prior to addition of 0.6 N HCl. Row A1 – A12: serial
1:10 dilutions 	
  
of S. equi lysate. Rows B – H, serial 1:2 fold dilutions of columns A1 – A12.
Figure 6. Same as Figure 5, following addition of stop solution (0.6 N HCl).
Figure 7. β-hemolysis and colony counting method (black dots). Darker growth in zigzag
pattern behind hemolytic colonies shows contaminant.
Figure 8. Confluent hemolysis that prevented the colonies from being counted accurately.
Figure 9: Regression of colony counts predicted from absorbance following ELISA in
water samples against actual colony counts of samples.
Table 1: Absorbance values (y) and their Corresponding Calculated Concentrations (x)
Using the Equation for the Line of Regression (y= 0.00005x – 0.2003), and
Colony Counts from the Blood Agar Plates.
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Introduction
Streptococcus equi subspecies equi is the causative agent of the disease Strangles
in horses (Sweeney et al., 2005). It forms abscesses in the lymph nodes of the head and
neck, and is highly contagious. There are approximately 1000 outbreaks of strangles in
the UK each year (Waller 2013). A survey within the US found that infection rates
during one outbreak were 17.6% of broodmares, 47.5% of one year old horses, and
37.5% of foals (Sweeney et. al., 1989). An affected horse should be quarantined to avoid
infecting other horses, but with the disease being so contagious, quarantine is often not
effective to prevent spread of the disease.
The bacteria are shed through mucous secretions and can persist in the
environment, being transmitted by people, flies or fomites (Weese et al., 2009). An
affected horse may not show clinical signs for six days, and may spread the infection
rapidly. Once quarantined, diligent effort must be made to contain the bacteria, but it
can be spread by flies: a vector that is impossible to control. After a horse has become
infected with strangles, the bacteria migrate to the guttural pouches, and may remain
there even after clinical signs have ceased. This can spread the infection to other horses,
because the S. equi is still persistent in the environment (Webb et al., 2013).
Because the bacteria are typically transmitted in the environment, environmental
sampling may be helpful in detecting an infection quickly. Sampling the environment
reduces the likelihood of transmission to other horses or contamination of equipment
while swabbing the nasal passage of a potentially infected horse. Despite exposure to
environmental factors like rain, heat, and sunshine, bacteria may persist on wooden fence
posts for up to three days (Weese et al., 2009). Detection of S. equi in environmental
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samples, such as drinking water or feces, may therefore facilitate surveillance for
strangles.
The objectives of this experiment therefore were to develop an assay to detect S.
equi by targeting the SeM protein, a major virulence factor. The SeM protein is the most
commonly studied antigen of S. equi because the variance found in the sequence does not
affect its ability to be opsonized by the immune system. This also means that the variance
should not affect whether the synthesized monoclonal antibodies can detect the different
strains (Waller, 2013).
Specific aims were to prepare dilutions of S. equi subsp. equi in decreasing
concentrations, and correlate with the optical density result of an ELISA using linear
regression, and then to evaluate the usefulness of the ELISA technique in estimating
numbers of viable bacteria in environmental samples such as water.
The hypotheses were that the ELISA will be able to detect S. equi at
concentrations of 10,000 CFU/mL, that there will be a linear relationship between the
concentration of bacteria in the sample and the absorbance values yielded by ELISA, and
that the assay can detect the bacteria from environmental samples, such as water.
Current Diagnostic Methods for Strangles
Identification of strangles has until recently relied on aerobic cultures from nasal
swabs or from nasopharyngeal washes. However, using a plated culture of the bacteria
can lead to many false negative results due to intermittent shedding. Taking the rectal
temperature daily may be effective in the detection of an infected animal, since horses
may show a fever 24 to 48h before the bacteria were able to be cultured from a mucosal
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swab, but this is inconvenient in most management settings. For this reason, point-of-care
diagnostic tests for strangles would be very valuable in controlling spread of the
organism. These tests could be applied to both the live animal and the environment.
The analysis of surface proteins is important in developing point-of-care tests for
S. equi, and especially for distinguishing S. equi from other bacteria. The surface proteins
of S. equi have been genetically mapped, allowing for comparison to other surface
proteins. Most of these proteins are involved in virulence, and in the case of S. equi, that
is the attachment to the tonsil and resistance to phagocytosis in the lymph nodes. This
may help it to persist as a colony in the guttural pouch for such prolonged periods of time
(Waller, 2013).
The SeM surface protein appears to be the major virulence factor for the
Streptococcus species because it is involved in the evasion from phagocytosis, and so it is
a good target for diagnostic tests (Sweeney et al., 2005). A diagnostic test to find the
presence of SeM, either genetically or antigenically, would appear ideal because
experiments have shown that the antibodies to SeM are produced throughout the course
of the disease more reliably than any other antibody (Sweeney et al., 2005). The amino
terminus is the least variable region, so targeting that sequence shows the most promise.
A polymerase chain reaction test can detect a specific nucleotide sequence of the
SeM protein of S. equi, and is an effective differential test to identify a horse with the
infection. The test can identify the gene encoding the SeM protein, and with the right
primers the test can be specific enough to catch only S. equi and sensitive enough to see
all of the bacteria present. The nucleotide sequences found in the gene for the SeM
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protein have some homology in strains of Streptococcus equi subspecies zooepidemicus
(S. zooepidemicus), but primers are available that are specific to the non – variable
terminus of the gene.
Polymerase Chain Reaction is also an important method used to reduce false
negatives, because it can isolate a gene unique to S. equi and detect it in a sample. Like
other diagnostic tools it targets the SeM gene, and appears three times more sensitive in
detecting clinical samples that were positive for S. equi than culture or biochemical tests.
Alternatively, researchers have developed PCR tests to other targets, the genes eqbE and
SEQ2190, allowing the PCR to produce fewer false negatives, because at least one copy
of either gene will likely be present across all strains (Webb et al., 2013). However, a
potential draw back of PCR is that dead bacterial DNA may yield a positive PCR result,
indicating that the horse is a shedder or currently infected, when it has instead cleared the
infection.
An alternative approach to detecting SeM in a point-of-care test is through direct
detection of the SeM antigen by Enzyme Linked Immunosorbent Assay (ELISA).
Monoclonal antibodies may be targeted to the amino terminus of the protein, because it is
less variable than the carboxyl terminus. However, this amino terminus is enveloped in
the membrane of the bacteria, requiring that it be digested with phage lysin. The phage
lysin digests the peptidoglycan of the cell wall, releasing the protein so that it can be
detected by the antibodies. This is an essential part of any SeM targeted antigenic assay,
because antibodies would not be able to detect the bacteria itself-only the exposed
protein.
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Above all, an antigenic test for S. equi must distinguish it from other bacteria in
a sample. The closely related S. zooepidemicus appears similar to S. equi when grown
on culture because both are β-hemolytic bacteria such that the agar turns from red to
clear where the colony of either organism is growing. However, there is a recurring
difficulty for differentiating S. equi from S. zooepidemicus, in finding a target molecule
that is sufficiently unique. Certainly, the SeM proteins on Streptococcus bacteria are
involved in the virulence, and lie on the outside wall of the bacteria, making them ideal
markers for tests. However if there is homology, then an antibody produced by the
body could cross-react with S. zooepidemicus. In terms of the immune response this is
a positive outcome, but in the detection of the disease it could lead to false positive test
results.
Monoclonal antibodies to SeM can cross-react with some S. zooepidemicus
strains, and efforts to improve specificity may decrease sensitivity because failing to
detect homologous epitopes will prevent detection of some SeM variants. An ELISA test
based on the amino terminus of the SeM protein shows most promise, as the test using
both of the two epitopes in that region identified 83/89 positive samples and 138/139
negative samples (Robinson et al., 2013). However, the closely related S. zooepidemicus
shares a homologous sequence of nucleotides near the carboxyl-terminus of the protein.
The antibodies specific to the SeM protein fragment can opsonize other species
of the bacteria, even though there is not a significant amount of homology in the
nucleotide sequences. Therefore there are other molecular factors involved in the
antibody-protein interaction than just the nucleotide sequence (Timoney et al., 1997).
This could pose an obvious problem for the specificity of an assay against S. equi.
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Although the SeM protein is a major virulence factor for the Streptococcus
species because it is involved in the evasion from phagocytosis, not all S. equi strains
have SeM, or they have a protein with a highly varied sequence. This brings up a
sensitivity issue for assays based on the detection of SeM. If the assay cannot detect the
strain, it would result in a false negative result, and would not be useful as a diagnostic
tool. The amino terminus is the least variable region, so an antibody complementary to
that sequence will be the most useful.
An alternative to an assay based on the SeM protein has been proposed which is
based on the SzPSe protein. Although it has a homolog in S. zooepidemicus, it is less
variable and more conserved than the SeM protein (Harrington et al., 2002). However
the occurrences of cross-reactive opsonization of S. zooepidemicus and lower
opsonizaton of S. equi are a drawback of this type of assay.
Another issue raised by detection of S. equi using an ELISA based on the SeM
protein (or any other antigen) is that due to the nature of the disease progression, when
there are no clinical signs but infection has occurred, as in the first 24 hours after initial
contact, the levels of SeM would not be detectable (Waller and Jolley, 2007). This would
lead to false negatives, continued spread of the disease and the inability to treat an animal
in an appropriate time frame.

Lessons Learned from Vaccination
A vaccine targeting the SeM protein sequence has been developed. This is
relevant to this research because it has shown that the SeM protein can confer immunity
after infection. However, the vaccine used only provides immunity against the particular
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strain that was targeted (Galan and Timoney 1988). This research shows the importance
of developing an assay to catch all of the strains of S. equi, to lower the false negative
results.
The strangles vaccines in development anticipate bacterial entry into the tonsil,
and then clonal expansion of a given S. equi strain in the guttural pouch. Once the
bacteria have colonized the guttural pouch, the horse has the potential to become a
lifetime shedder of the bacteria. A horse that is shedding the bacteria can be difficult to
identify, because clinical signs are not likely to be present anymore. However there may
be a change in the SeM during infection, altering the sensitivity and specificity of the
assay. This has been hypothesized as a cause for why strangles vaccines may sometimes
be ineffective, but also indicates that the diagnostic assay may not yield a positive result
when the sample comes from a shedder versus a recently infected horse. Thus the
diagnostic testing of the horses will have to be different than for those infected for the
first time (Timoney, 2007).
Materials and Methods
The ELISA protocol had to initially be tested, to be sure that all of the reagents
worked in the detecting of the SeM protein. Once it was known that they worked, a
standard curve could be made to correlate the optical density given by the
spectrophotometer to known dilutions of S. equi. The final step was to test how well the
ELISA worked in a realistic setting, so water samples were tested and the results
compared to the actual numbers of CFUs in the sample.
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Testing the reagents
The first step was to make a Phosphate Buffered Saline solution (PBS). The PBS
was made from 8 g of sodium chloride, 0.2 g of potassium chloride, 0.2 g of potassium
phosphate and 2.17 g of sodium phosphate heptahydrate to 900 mL of deionized water.
Then the pH was adjusted to 7.6 using 6M HCL and 5M NaOH, and then more water was
added to make it 1 L of solution. This was the coating buffer, used as a base to make the
wash buffer and the blocking buffer. The blocking buffer was made by adding 1 g of
Nonfat Dried Milk to 100 mL of coating buffer. The wash buffer was made by adding
0.05 mL of Tween 20 to 1000 mL of coating buffer. Once the buffers were made, the
detector antibody MAB211P, made by Maine Biotechnology Services (Portland, ME),
was biotinylated. To do so, 10 mg of biotin was dissolved in 250 µL of Dimethyl
Sulfoxide, and then 50 µL aliquots were made. Then 12 vials of MAB211P were
combined in a microfuge tube with five µL of biotin. It was incubated for an hour and
then dialyzed against 0.15M Phosphate Buffered Saline using a two mL Slide-A-Lyzer
Mini dialysis device for two hours. Then the PBS was changed and dialyzed for another
two hours. An assay that uses a HABA/avidin complex was used to determine that the
biotinylation was successful. In the presence of biotin, the biotin molecule will replace
the HABA in the complex, so that the HABA can be measured with an absorbance
reading at 500 nm. To run this assay, 180 µL of HABA/avidin was added to five wells
and shaken for five minutes, after which the absorbance was read. Then 20 µL of the
biotinylated MAB211P was added to each well, shaken for another five minutes, and the
absorbance read at 500 nm. Each of the five wells had a different sample of MAB211P
added, because 20 µL samples were recovered once every hour during dialysis, and
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immediately after the PBS solution was changed. Then the molar ratio of biotin to
antibody was calculated using a computer program called R. A successful biotinylation
resulted in five to eight biotin molecules per antibody molecule.
For the assay, each well of a 96-well plate was coated with 50 µL of monoclonal
capture antibody MAB212P, made by Maine Biotechnology Services (Portland, ME) and
incubated overnight, covered and in the refrigerator. To add the reagents throughout the
assay a multichannel pipette was used. Then the plate was washed using an automated
plate washer, and each well was coated with 50 µL Nonfat Dried Milk in PBS solution,
which acted as a blocking buffer. This was incubated for one hour at room temperature
and with rotation, and then the wells were washed again using the automated plate
washer. Then 50 µL of PBS was added to each well, followed 50 µL of the samples into
the wells that were assigned to them. The plate has eight rows and 12 columns, and so the
sample went into the first column in each row. Then serial dilutions were made across the
rows, by successively taking 50 µL from the previous well and moving it to the next well
and mixing it eight times using a pipette. This way, it was known that all of the samples
had been diluted significantly and it would be possible to visualize whether the color
change was less dramatic with a more dilute solution. Each sample had been digested
using five µL of Phage lysin C, and had incubated at 37 degrees Celsius for 30 minutes.
The samples incubated in the wells for 30 minutes at 37 degrees Celsius, and then the
wells were washed again. Next 50 µL of the detector antibody MAB211P conjugated to
biotin was added to each well, the plate incubated for an hour then was washed. The
detector antibody and biotin had been diluted to a concentration of 0.5 µg/mL by adding
50µL of the solution to ten mL of PBS. Then 50 µL of Streptavidin Horseradish
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Peroxidase, diluted in wash buffer at a concentration of one µg/mL was added to each
well to bind to the antibodies. This incubated in the wells for 30 minutes at 37 degrees
Celsius and the wells were washed four times. Then 50 µL of TMB (3,3′,5,5′tetramethylbenzidine) was added to each well, acting as a substrate for the enzyme. As
the reaction proceeds the solution in the well turned blue. The reaction was allowed to
run for 10 minutes, and then it was stopped by adding 50 µL of 0.6M hydrochloric acid to
each well. The results were read at 450nm absorbance using a spectrophotometer.
Initial assay validation
Once the MAB211P was biotinylated successfully, the Enzyme Linked Immunosorbent Assay was run using dilutions of samples that were known to be positive (fresh
culture of S. equi and two S. equi lysates stored at -20 C for 2 years as positive), samples
that were known to be negative (lysate of Streptococcus equi subspecies zooepidemicus),
and compared to the results of using buffer in place of a sample, and dilutions of bacteria
grown on blood agar plates.
Creating a standard curve
First a lawn of S. equi was grown on three blood agar plates. Then the bacteria
was suspended in PBS solution by harvesting the bacteria from the three plates using a
cotton swab, and twirling the swab in a micro-centrifuge tube filled with 1 mL of PBS,
which released the bacteria into solution. One to ten serial dilutions into PBS were made
by adding 900 µL of PBS to 11 tubes and serially transferring 100 µL of bacterial
solution across the tubes, and then 10 µL of each dilution was plated onto a separate
blood agar plate, and incubated overnight. Then the colonies were counted on each plate
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to calculate the concentration of bacteria that was in each diluted solution. Then 5 µL of
Phage lysin C was added to each tube that had one mL of the sample, and the tube was
incubated for 30 minutes at 37 degrees Celsius. The samples were treated with phage
lysin to release the M protein from the rest of the bacteria. Since there were twelve
separate concentrations, they were added across the top row of the plate, and then were
serially diluted down their respective columns. Then the ELISA assay was run according
to the same protocol as before.
Statistical Analysis
To create the standard curve, the absorbance readings were plotted against the
concentration of the sample in that well. This data can be found in Appendix 1. The
scatter plot of these values can be found in Figure 1. There were some wells in the first
two columns whose absorbance was so high that the spectrophotometer results only read
overflow, with no numerical value, so they were excluded them from the graph. The
horizontal axis of the graph is formatted in a logarithmic form, to better visualize the first
part of the data, which was originally too close together to make any analysis. The point
where the slope of the standard curve flattens indicates that the assay can no longer detect
changes in concentration, because although the concentration is decreasing the
absorbance reading is the same. The points on the graph before the curve flattens show
the linear relationship of the optical density and the concentration of bacteria, so those
points were plotted on a second graph, shown in Figure 2. This data can be found in
Appendix 1.

11	
  
	
  

Testing Water Samples
The next step was to determine how accurate the standard curve is when used
with environmental samples. This step is based on the infectious dose of the bacteria,
which is 10,000 CFU, and that the typical horse drinks about 10 gallons of water per day.
Working with a 10 gallon bucket of infectious water is not safe, the concentration of the
infectious dose was calculated to be 0.264 CFU/mL. This was multiplied by 10 mL, so to
make the proper dilution three isolated CFUs were added to 10 mL of tap water.
The ELISA relies on the detection of specific bacteria, so it was important to
know that a contaminant was not being used instead of the S. equi. To do so, samples that
were supposedly S. equi were streaked for isolation on blood agar plates. Once they grew
and exhibited the typical β-hemolysis of the blood, an isolated colony was gram stained
to be sure that it was a gram positive streptococci. The final differential test was the
fermentation of specific sugars. S. equi ssp. Equi does not ferment lactose, mannitol,
trehalose or sorbitol, while other subspecies do ferment one or some of those particular
sugars. To determine whether the sugar was utilized, colonies were swabbed and added to
a solution of each sugar. They incubated overnight at 37 degrees Celsius, and
fermentation was indicated by a change in color from red to yellow. None of the sugar
solutions changed color, so it was determined that the isolated colonies were in fact S.
equi.
From the 10 mL of tap water that had been inoculated with three isolated
colonies, the bacteria was collected using a cotton swab and transferred to one mL of
PBS. This was intended to mimic the realistic collection of bacteria from a sample
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intended to be analyzed. The bacteria needed to be transferred to the PBS because the
phage lysin is only functional at the specific pH of the PBS. From the one mL sample,
serial dilutions were made, by pipetting 100 µL of the original solution into 900 µL of
PBS. Three serial dilutions were made from the original in this way. The process of
swabbing the water sample and performing three serial dilutions was then repeated twice
more to ensure that the bacteria had been captured from the water sample. This resulted
in 12 samples that could then be tested.
Before the 12 samples were digested in phage lysin, 100 µL was taken from each
and pipetted onto a corresponding blood agar plate, then spread for colony isolation using
a sterile loop for each plate. This step was intended to be a check against the ELISA
results, because the colonies could be counted and compared to what the test indicated.
Then 50 µL of each of the 12 samples were run through the same ELISA protocol
as described previously, and their absorbance was measured using the spectrophotometer.
The blood agar plates incubated overnight at 37 degrees Celsius, and the colonies were
counted based on the hemolysis that they showed.
Results and Discussion
Initial Assay Validation
Results of the initial assay are shown in Figure 1 and 2. The assay correctly
identified S. equi positive samples. The decrease in signal strength of three dilutions of
S. equi indicated a quantitative relationship. Additionally, the assay did not recognize
samples of S. zooepidemicus or reagent buffer free of Streptococci.
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Standard Curve

Graphical plot of all the data from 96 points used in standard curve estimation is
shown in Figure 3.The data from the linear part of the graph shows that there is
correlation between the absorbance value and the concentration of bacteria, with the
slope of the line of regression as 0.00005 (Figure 4). The R2 value is 0.9258, indicating
that the correlation shown by the line of regression is strong. The scatter plot of the data
confirms the hypothesis: an increase in the concentration of SeM will result in a linear
increase in the absorbance value that is read. The other hypothesis, that the test could
detect the SeM protein and result in a color change was also correct. The assay could
accurately detect a range of concentrations from 78,125 CFU/mL to 15,000 CFU/mL.
This is not accurate enough to match the infectious dose of the bacteria, but more tests
can be done to refine these results. The ELISA plates before and after addition of the stop
solution are shown in Figures 5 and 6.

Environmental Sample Testing

The second part of the project, which involved a realistic water bucket sampling,
did not yield a significant relationship. The output value of the concentration was
calculated when absorbance values were entered into the regression model given by the
standard curve. This data is shown in Table 1. The colonies on the plates were more than
a factor of 10 different from what the absorbance values indicated. This may be due to
several factors. First, a colony forming unit is not necessarily one bacterium, especially in
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the case of a Streptococcus, which tends to be grouped as a string of bacteria. Therefore it
was impossible to get an accurate count of bacteria just by doing colony counts. Also,
since each CFU that was formed can have different numbers of bacteria, the colonies
used to inoculate the water sample had a significant level of variation. Another source of
inaccuracy is that since tap water was used as the initial sample, there were contaminants
on the plates that clouded the S. equi colonies on top of the agar. This forced the colony
count to rely on the hemolysis of the blood that showed through to the outside of the plate
(Figure 7). Anecdotally, there is usually more than one colony per cleared circle on the
plate, so by only counting the circles of hemolysis, the actual number of colonies would
be underestimated. All of the plates that were grown using a sample which had not been
diluted had growth that was too confluent to count (Figure 8), so the colony count was
estimated to be 300 CFUs, which is the upper limit of what is countable, and then it was
multiplied by 10 to account for the fact that the plates had one tenth of the original PBS
solution, as was done for all of the plate counts. The regression coefficient obtained when
predicted colony counts from absorbance data were compared with actual colony counts
(Figure 9) did not indicate a strong relationship (R2 = 0.0028).
Conclusion
In conclusion, the ELISA assay was sensitive enough to detect a concentration of
at least 15,000 CFU/mL, which is slightly higher than the 10,000 CFU/ mL stated in the
hypothesis, but within the order of magnitude expected of the test. The relationship had a
strong regression coefficient (R2 = 0.93). Overall the data would tend to support the
hypothesis, but further testing is necessary. While positive results were obtained in water
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samples containing S. equi, contamination and confluence of colonies made it impossible
to confirm a linear relationship between absorbance and colony counts.
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Tables and Figures

Figure 1. Initial validation of ELISA assay. Row A1-A12: serially diluted S. equi. Row
B1-B12: 100 fold dilution of row A. Row C1-C12: 10,000 dilution of row A. Rows D112 and E1-E12: Buffer only. Row F1-F12: 2012 Lysate # 1 of S. equi. Row G1-G12:
2012 Lysate # 2 of S. equi. Row H1-H12: 2012 Lysate of S. zooepidemicus.
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Figure 2. Same as Figure 1, following addition of stop solution (0.6 N HCl).
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Figure 3. Graphical representation of absorbance readings (450 nm) following ELISA of
96 different concentrations of S. equi.
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Linear Relationship of the Standard Curve
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  -‐	
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R²	
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Figure 4. Regression of absorbance values derived from ELISA of S. equi at
concentrations in the linear region of the standard curve shown in Figure 3.

Figure 5. ELISA plate from standard curve calculation after the addition of
tetramethylbenzidine, but prior to addition of 0.6 N HCl. Row A1 – A12: serial 1:10
dilutions of S. equi lysate. Rows B – H, serial 1:2 fold dilutions of columns A1 – A12.
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Figure 6. Same as Figure 5, following addition of stop solution (0.6 N HCl).

Figure 7. β-hemolysis and colony counting method (black dots). Darker growth in zigzag
pattern behind hemolytic colonies shows contaminant.
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Figure 8. Confluent hemolysis that prevented the colonies from being counted accurately.
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Figure 9: Regression of colony counts predicted from absorbance following ELISA in
water samples against actual colony counts of samples.
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Table 1: Absorbance values (y) and their Corresponding Calculated Concentrations (x)
Using the Equation for the Line of Regression (y= 0.00005x – 0.2003), and Colony
Counts from the Blood Agar Plates.
Plate
Number
A
A1
A2
A3
B
B1
B2
B3
C
C1
C2
C3

ABS (y)
0.512
0.51
0.381
0.418
0.531
0.494
0.6
1.01
0.774
1.133
1.027
0.397

CFU/mL
(x)
14246
14206
11626
12366
14626
13886
16006
24206
19486
26666
24546
11946

CFU/mL from
plate counts
3000
950
320
40
3000
1250
140
40
3000
1060
280
30
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Appendix 1: Data
Table A 1: Absorbance Values and Concentrations of Bacteria Used in the Standard
Curve.
_____________________________________________________________________
CFU/mL

ABS

CFU/mL

ABS

CFU/mL

ABS

50000000

OVRFLW

3125

0.505

3.75

0.961

25000000

OVRFLW

3000

0.433

2.34375

0.977

12500000

OVRFLW

1875

0.586

1.875

0.474

6250000

OVRFLW

1562.5

0.463

1.5

0.712

5000000

OVRFLW

1500

0.5

1.171875

0.781

3125000

OVRFLW

1500

1.244

0.9375

0.388

2500000

OVRFLW

937.5

0.63

0.75

0.446

1562500

OVRFLW

781.25

0.887

0.46875

0.708

1250000

OVRFLW

750

0.406

0.375

0.57

781250

OVRFLW

750

0.456

0.234375

0.937

625000

OVRFLW

468.75

0.597

0.1875

0.393

500000

3.17

390.625

0.873

0.15

0.664

390625

OVRFLW

375

0.528

0.117188

0.601

312500

OVRFLW

375

0.393

0.09375

0.3

250000

2.867

234.375

0.488

0.075

0.442

156250

3.819

187.5

0.729

0.046875

0.895

125000

1.999

187.5

0.477

0.0375

0.653

78125

3.571

150

0.736

0.023438

0.681

62500

1.04

93.75

0.541

0.01875

0.618

50000

0.693

93.75

0.268

0.015

0.443

39062.5

3.237

75

0.602

0.011719

0.816

31250

1.079

46.875

0.559

0.009375

0.48

30000

1.394

46.875

0.309

0.0075

0.803

25000

0.565

37.5

0.405

0.004688

0.728

15625

1.019

23.4375

0.463

0.00375

0.411

15000

0.404

23.4375

0.733

0.002344

0.36

12500

0.424

18.75

0.987

0.001875

0.517

7812.5

0.479

15

0.427

0.001172

0.531

7500

0.404

11.71875

0.655

0.000938

0.412

6250

0.646

9.375

0.295

0.000469

0.517

3906.25

0.776

7.5

0.708

0.000234

0.396

3750

0.696

4.6875

0.297

0.000117

0.509
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Table A 2: Data points in the linear region of standard curve that showed a linear
relationship.
CFU/mL

Abs

78125
31250
30000
25000
15625
15000

3.571
1.079
1.394
0.565
1.019
0.404
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Appendix 2: Protocol Flow sheets and Reagent Preparation Sheets

Elisa protocol flow sheet
Name:
Date:
I. Hazard Assessment
To protect yourself from any possible hazards associated with this task wear eye protection. You
should also wear latex, nitrile, or vinyl gloves and a lab coat with long sleeves. To protect your legs
and feet wear closed shoes and long trowsers. Do not wear sandles, shorts or a short skirt. Wash
your hands before eating and when leaving the laboratory. You should review the MSDS for any
chemical used in this procedure. In case of a spill with a toxic chemical remove all contaminated
clothing and wash affected areas with copious quantities of water. Check location of the nearest
safety shower. Eyes should be washed copiously for 15 minutes.
When preparing 0.6 N Hydrochloric acid solution wear goggles that form a seal and nitrile gloves.
Always add the acid to the water, not vice versa.
This protocol is based on the Maine Biotechnology Services ELISA protococol for SeM.
II. Reagents and supplies
Reagent

Amount

Coating buffer (0.15 M PBS, pH 7.6)
Capture Antibody - MAB212 diluted in coating buffer (2 ug/mL)
Wash Buffer (0.15 M PBS, 0.05% tween 20)
Blocking Buffer (1% Non Fat Dried Milk (NFDM) in 0.15 M PBS)
Sample: phagelysin digested sample, variable dilution profiles, 50
uL per well,
Detector Antibody MAB211-biotin diluted in blocking buffer (0.5
ug/mL)
Tracer Streptavidin Horse Radish Peroxidase (HRP) diluted in wash
buffer (1:10,000)
Substrate, which is turned blue by HRP, TMBW (undiluted - single
step reagent)
Stop solution which causes blue to yellow color change (0.6 N
Hydrochloric acid)

1 liter
10 mL
1 liter
100 ml
as
needed

Material
ELISA Plates
Plate washer
Multichannel pipette
Unichannel pipettes
Pipette tips
Reagent tubes

Yes

____

10 mL

Yes

____

10 mL

Yes

____

10 mL

No

____

10 ml

No

____

____
____
____
____
____
____
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Separate
Ready
SOP?
Yes
____
Yes
____
Yes
____
Yes
____

Reagent boats

____

Comments:

III. Coating Plates
Label Plates
____
Dispense 50 ul of 2 ug/ml MAB212 capture antibody to all wells** ____
Cover and refridgerate at 4 C overnight
____
**Use Multichannel pipette
Comments:

IV. Wash Plates post-coating
Wash # 1with automatic plate washer (0.15 M PBS, 0.05% tween 20), fill 300 uL ____
Flick then blot dry
____
Comments:

V. Blocking
Prepare blocking buffer (1 g NFDM in 100 mL PBS)
____
Label expiration date 1 week from date of preparation
____
Dispense 300 ul of Blocking Buffer (1% Non Fat Dried Milk in 0.15 M PBS) to all wells** ____
Refridgerate any excess blocking buffer
____
Incubate plates at room temperature for 1 hour or overnight at 4 C
____
**Use Multichannel pipette
Comments:
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VI. Wash Plates post blocking
Wash # 1with automatic plate washer (0.15 M PBS, 0.05% tween 20), fill 300 uL ____
Flick then blot dry
____
Comments:

VII. Arrangent of samples by serial dilution 1:2 (or 1:6)
Prepare phagelysin digested samples/controls in dilution tubes, label and record on summary
sheet
Dispense 50 ul of 0.15 M PBS to all wells
Add 50 ul (or 10 ul) of samples to rows in column 1*
Transfer 50 ul (or 10 ul) to column 2**
Repeat transfer through row 12**
Discard the last 50 ul (or 10 ul) from row 12
Incubate plates with rotation at 37 C for 30 minutes or at room temp for 1 hour
During this incubation, prepare a 0.5 ug/ml solution of the detector antibody
MAB211P-biotin, in blocking buffer (1% NFDM in 0.15 M PBS; see separate SOP)

____
____
____
____
____
____
____
____

*Use single channel pipette
**Use Multichannel pipette, mixing 8 X before each transfer
Comments:

VIII. Wash Plates post sample incubation
Wash # 1with automatic plate washer (0.15 M PBS, 0.05% tween 20), fill 300 uL ____
Flick then blot dry
____
Comments:

IX. Addition of Detector Antibody MAB211P-Biotin
Pipet 50 ul well of the detector antibody (MAB211P-biotin) to each well**
Incubate at 37C for 30 minutes or 1 hour at RT, with rotation if possible.
During this incubation, prepare a 1:10,000 dilution of the Streptavidin HRP in wash
buffer. See separate SOP
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____
____
____

**Use Multichannel pipette
Comments:

X. Wash Plates post incubation with MAB211P-Biotin Detector
Wash # 1 with automatic plate washer (0.15 M PBS, 0.05% tween 20), fill 300 uL ____
Flick then blot dry
____
Comments:

XI. Addition of Streptavidin HRP
Pipet 50 ul of the Streptavidin HRP at 1:10,000 to each well**
____
Incubate at 37C for 30 minutes or 1 hour at RT, with rotation if possible. ____
**Use Multichannel pipette
Comments:

XII. Wash plates post incubation with Streptavidin HRP
Wash # 1 with automatic plate washer (0.15 M PBS, 0.05% tween 20), fill 300 uL ____
Wash # 2 with automatic plate washer (0.15 M PBS, 0.05% tween 20), fill 300 uL ____
Wash # 3 with automatic plate washer (0.15 M PBS, 0.05% tween 20), fill 300 uL ____
Wash # 4 with automatic plate washer (0.15 M PBS, 0.05% tween 20), fill 300 uL ____
Flick then blot dry
____
Comments:

XIII. Addition of TMBW color reagent
Add 50 ul of the TMB to each well on plate **
____
Start timer for 10 minutes and cover plate**
____
After 10 minutes, stop the enzyme reaction by adding 50 ul of 0.6N HCL ____
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Read the plate at A(450 nm)

____

**Use Multichannel pipette
Comments:
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Reagent Preparation Sheet.
0.15M PBS, pH 7.6, coating buffer
ELISA Coating Buffer
Date prepared:
By:
I. Hazard Assessment
To protect yourself from any possible hazards associated with this task wear eye protection.
You should also wear latex, nitrile, or vinyl gloves and a lab coat with long sleeves. To
protect your legs and feet wear closed shoes and long trowsers. Do not wear sandles, shorts
or a short skirt. Wash your hands before eating and when leaving the laboratory. You should
review the MSDS for any chemical used in this procedure. In case of a spill with a toxic
chemical remove all contaminated clothing and wash affected areas with copious quantities
of water. Check location of the nearest safety shower. Eyes should be washed copiously for
15 minutes.
II. Buffer
0.15M PBS, pH 7.6, coating buffer
III. Purpose of buffer
Basis buffer in SeM ELISA protocol for coating plates with MAB212p, also the 1X PBS
used in blocking, washing and antibody dilution.
IV. Buffer recipe
Reagent
Amount
sodium chloride
8.0 g
Potassium chloride
0.2 g
KH2PO4
0.2 g
Na2HPO4.7H20
2.17 g
water
900 ml
Adjust pH to 7.6 with 6N HCL or 5N NaOH as necessary
Add water to 1 liter
V. Comments
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Added
____
____
____
____
____
____
____

Reagent Preparation Sheet.
Working dilution of MAB212p in coating buffer for coating ELISA plates
at a concentration of 2 ug/mL
Date prepared:
By:
I. Hazard Assessment
To protect yourself from any possible hazards associated with this task wear eye protection.
You should also wear latex, nitrile, or vinyl gloves and a lab coat with long sleeves. To
protect your legs and feet wear closed shoes and long trowsers. Do not wear sandles, shorts
or a short skirt. Wash your hands before eating and when leaving the laboratory. You should
review the MSDS for any chemical used in this procedure. In case of a spill with a toxic
chemical remove all contaminated clothing and wash affected areas with copious quantities
of water. Check location of the nearest safety shower. Eyes should be washed copiously for
15 minutes.
II. Reagent
MAB212p dilution in coating buffer for SeM ELISA
III. Purpose of reagent
Serves as the capture antibody MAB212p for SeM ELISA. This antibody serves as the
coating agent on the ELISA plate to concentrate target SeM and Sem containing
streptococci.
IV. Reconstituted vial and storage
5 Vials (1 mL) received at 1.4mg/mL. Aliquotted into 50 ul aliquots and frozen at -20 C.
V. To prepare a working dilution
Number of moles in 10 mL @ 2 ug/mL = Number of moles in x mL @ 1.4 mg/ml (added to
10 mL buffer)
10 mL X 2 ug/mL = x mL X 1.4 mg/mL
10 mL X 2 ug/mL = x mL X 1400 ug/mL
x mL = (10 mL X 2 ug/mL)/ 1400ug/mL solve for x
x ul = 1000 *(10 mL X 2 ug/mL)/1400ug/mL give volume in uL
x ul = (10 mL X 2 ug/mL)/1.4 mg/mL 1000's cancel out
x = 10*2/1.4 yields volume (in uL) of MAB212p @ 1.4 mg/mL to add to 10 mL to make a 2
ug/mL solution in uL
The R code to generate table below
> y=c(1.2,1.3,1.4,1.5) # a variety of concentrations, including the 1.4 mg/mL used in the
example
> x=10*2/y; x #prints volumes (uL) to add of each concentration
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[1] 16.66667 15.38462 14.28571 13.33333
Original concentration MAB212p
Volume MAB212p to use
Volume of coating buffer (0.15M PBS, pH
7.6)
Check which volume used

1.2
mg/mL
16 ul

1.3
mg/mL
15 ul

1.4
mg/mL
14 uL

1.5
mg/mL
13 ul

10 mL

10 mL

10 mL

10 mL

____

____

____

____

VI. Comments
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Reagent Preparation Sheet.
Preparation of Phage Lysin digested sample for SeM ELISA
Date prepared:
By:
I. Hazard Assessment
To protect yourself from any possible hazards associated with this task wear eye protection.
You should also wear latex, nitrile, or vinyl gloves and a lab coat with long sleeves. To
protect your legs and feet wear closed shoes and long trowsers. Do not wear sandles, shorts
or a short skirt. Wash your hands before eating and when leaving the laboratory. You should
review the MSDS for any chemical used in this procedure. In case of a spill with a toxic
chemical remove all contaminated clothing and wash affected areas with copious quantities
of water. Check location of the nearest safety shower. Eyes should be washed copiously for
15 minutes.
II. Reagent
Phage lysin digest of sample for SeM ELISA.
III. Purpose of reagent
The Phage Lysin C (PlyC) releases SeM from the wall of Streptococcus equi by digesting
the peptidoglycan. This exposes epitopes on the SeM protein which are recognized by
MAB212p (capture) and MAB211p (detector) monoclonal antibodies.
IV. Reconstituted vial and storage
Phage lysin was received at 5 mg/ml (i.e. 5 ug/ul) and aliquotted into 50 ul aliquots and
frozen at -20 C.
V. To digest sample
The following method is used to digest the sample. The sample is intended to be on a cotton
swab. This would be either a clinical swab, a swab placed in compost, a swab swept through
the water (or over the plastic surface) of a water bucket, or a swab drawn over a blood plate
to harvest streptococcal colonies
Twirl swab in 1 mL of PBS (0.15 M, pH 7.6)
Add 5 ul of phage lysin
Incubate 30 minutes at 37 C
Label, date and store unused digest at - 20 C

_____
_____
_____
_____

VI. Comments
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Reagent Preparation Sheet.
Preparation of Biotinylated MAB211p, SeM detector antibody in ELISA
protocol.
Date prepared:
By:
I. Hazard Assessment
To protect yourself from any possible hazards associated with this task wear eye protection.
You should also wear latex, nitrile, or vinyl gloves and a lab coat with long sleeves. To
protect your legs and feet wear closed shoes and long trowsers. Do not wear sandles, shorts
or a short skirt. Wash your hands before eating and when leaving the laboratory. You should
review the MSDS for any chemical used in this procedure. In case of a spill with a toxic
chemical remove all contaminated clothing and wash affected areas with copious quantities
of water. Check location of the nearest safety shower. Eyes should be washed copiously for
15 minutes.
II. Reagent
Biotin conjugated MAB211p.
III. Purpose of reagent
The monoclonal IgG antibody used in detection of SeM antigen of Streptococcus equi
subspecies equi. In ELISA format , it is used in conjunction with MAB212, the latter being
a capture antibody to concentrate target on the ELISA plate.
IV. Reconstitution and storage of Biotin
Dissolve vial of biotin (10mg) in 250 ul of DMSO. This gives a final concentration
____
of 40 mg/mL
Make 50 ul aliquots of biotin at 40 mg/mL (i.e. 5 aliquots at 50 ul) and store at - 20 C ____
V. Biotinylation procedure
In a 1.5 mL microfuge tube combine 12 (50 ul) vials of MAB211p (tracer antibody)
(12 X 75ug = 900ug of MAB211p and 12 X 50ul = 600 ul total volume)
To this add 5 ul of biotin (5 ul X 40 mg/mL = 0.2 mg)
Mix and incubate at room temperature for an hour
Dialyse this volume (600 uL) against 0.15M PBS using a 2 mL Slide-A-Lyzer MINI
Dialysis Device for 2 hours at room temperature, twice with 20 kD Molecular weight
cut-off (20K MWCO).
Reconstitute with PBS up to a volume of 900 uL (~1 mg/mL) and make 50 ul
aliquots (each at ~1 mg/mL i.e. 50 ug) and freeze aliquots at -20 C.
When ready to conduct ELISA, add 1 aliquot of biotinylated antibody (50 ug) to 10
mL of blocking buffer (0.15 M PBS with 1 % NFDM) to have a final concentration
of 0.5 ug/mL of detector antibody in blocking buffer.
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____
____
____
____
____
____

VI. Assessment of biotinylation using HABA/AVIDIN BIOTIN replacement assay
The assay provides a colometric assessment of displacement of HABA from its complex
with AVIDIN by biotin. The HABA/AVIDIN complex is measured at A500, and its
reduction in absorbance can be directly correlated to moles of HABA being replaced by
biotin.
Reconstitute HABA/AVIDIN vial (Sigma H 2153) with 10
mL of deionized water.
(Use needle and syringe.)
Label vial "exp" and date one month from today, store at 04C
Add 180 ul of HABA/AVIDIN solution to well. Shake 5
min
Record absorbance at 500 nm
Record concentration of biotinylated MAB211p mg/mL
Add 20 ul of biotinylated MAB 211p to same well. Shake 5
min
Record absorbance at 500 nm
(If absorbance < 0.15 dilute sample and repeat assay)
Calculate molar ratio of biotin to protein (target is 5 - 8)

____
____
____
____ A500 HA
____ mg/ml mgmlpro
____
____ A500HAB
____

moles of biotin per
mole of protein

VII. R code Calculations
In the formula below fill in values xxx for mgmlpro, A500HA, and A500HAB. The formula
generates the biotin to protein molar ratio and an array with values including DA (difference
in absorbance), mmol per mL of biotin (mmolmlbio), mmol per mL of protein (mmolmlpro)
and the last value is also the biotin to protein molar ration (bio2pro).
Formula for microplate
mgmlpro=xxx; A500HA=xxx; A500HAB=xxx;DA=(A500HA)-A500HAB;
mmolmlbio=DA/(34000*0.5);mmolmlpro=mgmlpro/150000;bio2pro=
(mmolmlbio*10)/mmolmlpro;bio2pro; rbind(mgmlpro,A500HA, A500HAB, DA,
mmolmlpro,mmolmlbio,bio2pro)#for microplate
In R paste the text after the command prompt ">". For example:
> mgmlpro=0.69; A500HA=0.904; A500HAB=0.771;DA=(A500HA)-A500HAB;
mmolmlbio=DA/(34000*0.5);mmolmlpro=mgmlpro/150000;bio2pro=
(mmolmlbio*10)/mmolmlpro;bio2pro; rbind(mgmlpro,A500HA, A500HAB, DA,
mmolmlpro,mmolmlbio,bio2pro)#for microplate
[1] 17.00767
[,1]
mgmlpro 6.900000e-01
A500HA 9.040000e-01
A500HAB 7.710000e-01
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DA
1.330000e-01
mmolmlpro 4.600000e-06
mmolmlbio 7.823529e-06
bio2pro
1.700767e+01
Formula for cuvette.
mgmlpro=xxx; A500HA=xxx; A500HAB=xxx;DA=(0.9*A500HA)-A500HAB;
mmolmlbio=DA/(34000*1);mmolmlpro=mgmlpro/150000;bio2pro=
(mmolmlbio*10)/mmolmlpro;bio2pro; rbind(mgmlpro,A500HA, A500HAB, DA,
mmolmlpro,mmolmlbio,bio2pro)#for cuvette
Refer to instructions for HABA/AVIDIN for how to perform assay in a cuvette system. The
formula is adjusted slightly to adjust for change in absorbance with addition of sample (0.9),
and different pathwidth of cuvette (1 cm) versus microtitre plate (0.5 cm)
VIII. Comments
Biotinamidocaproate N-Hydroxy-Succinimide ester provides more detailed information
about biotin
(Sigma H 2153) gives detailed information about the HABA/AVIDIN reagent from Sigma
used in this protocol, including instructions on how to reconstitute and store reagent.
HABA/AVIDIN gives detailed explanation and background information on the assay, and
how to perform calculations. But instructions on how to reconstitute the vial are not
applicable to this protocol since we use a different product (Sigma H 2153)
Slide-A-Lyzer detailed explanation and background information for slide-alyzer dilaysis
system
Ordering Information:
www.Sigmaaldrich.com
Biotin - Biotinamidohexanoic acid N-hydroxysuccinimide ester 10 mg # B264310MG $29.90
Dimethyl sulfoxide CHROMASOLV Plu # 34869-100ML $66.30
HABA/Avidin Reagent lyophilized powder # H2153-1VL $39.50
www.piercenet.com
Slide-A-Lyzer MINI Dialysis Device, 20 Kdalton Molecular Weight Cut-Off (20K
MWCO), 2mL (pack of 25 devices) catalog # 88405 $220.
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Reagent Preparation Sheet.
Conjugated-Streptavidin horse radish peroxidase
Date prepared:
By:
I. Hazard Assessment
To protect yourself from any possible hazards associated with this task wear eye protection.
You should also wear latex, nitrile, or vinyl gloves and a lab coat with long sleeves. To
protect your legs and feet wear closed shoes and long trowsers. Do not wear sandles, shorts
or a short skirt. Wash your hands before eating and when leaving the laboratory. You should
review the MSDS for any chemical used in this procedure. In case of a spill with a toxic
chemical remove all contaminated clothing and wash affected areas with copious quantities
of water. Check location of the nearest safety shower. Eyes should be washed copiously for
15 minutes.
II. Reagent
Peroxidase-conjugated Streptavidin
III. Purpose of reagent
Streptavidin is a protein derived from Streptomyces avidinii. Streptavidin binds biotin
(vitamin B7) in one of the strongest non-covalent interactions known.
The HorseRadish Peroxidase enzyme is made visible when it catalyzes oxidation of a
substrate by hydrogen peroxide. Substrates are chosen which change color on oxidation, and
the presence of the HRP or an HRP-conjugate can then be detected by spectrophotometry.
In this case the HRP is conjugated to Avidin, which binds to the biotin on MAB211p, which
is the monoclonal antibody binding specific epitopes on SeM.
The substrate used in the SeM ELISA protocol is tetramethylbenzidine (TMB). When
oxidized by HRP it turns blue (read absorbance at 650 nm), but following stopping the
reaction using 0.6 N HCL, it turns yellow (read absorbance at 450 nm)
IV. Reconstituted vial and storage
Add 1.0 mL dH2O to 1 vial (1.0 mg) freeze dried powder ____ (1 mg/ml)
Centrifuge product if not clear
____
Store at 2-8 C
____
Label vial "exp" followed by date 6 weeks in the future ____
V. To prepare a working dilution
Should be done fresh each day:
Dilution

0.1 ug/mL 1 ug/mL* 2 ug/mL
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Check dilution used
____
Final "Dilution"
1:100,000
Peroxidase-HRP stock diluted 1:10 (1 mg/mL)
1 uL
Volume of wash buffer (0.15M PBS, 0.05% tween 20) 10 mL

____
1:10,000*
10 ul*
10 mL*

____
1:5,000
20 ul
10 mL

*This is the dilution specified in the SeM ELISA Protocol.
VI. Comments
HRP-Streptavidin provides more technical details.
Ordering Information:
www.jacksonimmuno.com
Jackson Immunoresearch, Peroxidase-conjugated streptavidin, 1.0 mg as freeze-dried
powder. The catalog # is 016-030-084.
TMB provides more detailed technical information
Ordering Information:
www.surmodics.com
TMB One Component HRP Microwell Substrate # 1000-01 TMBW 100mL
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